Demand for Wegovy Exceeds Supply.
When Wegovy started to take off due to the massive consumer marketing and celebrity/influencer endorsements, Novo literally could not make the drug fast enough.
So, to satiate the wild demand, physicians started prescribing Ozempic, even though it was only FDA approved for type 2 diabetes, for weight loss. As more and more doctors took advantage of this “loophole,” the result was disturbing: diabetics could not get their hands on the drug, even though they needed it to manage their diabetes.
Yes, you read that right: massive over-prescribing of Ozempic for weight loss caused a shortage of the drug, and diabetics – the people who actually need Ozempic to manage a very serious life-long health condition – could not get the drug.